Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-α: Follow-up results

Hagop M. Kantarjian, Moshe Talpaz, Susan O'Brien, Terry L. Smith, Francis J. Giles, Stefan Faderl, Deborah A. Thomas, Guillermo Garcia-Manero, Jean Pierre J. Issa, Michael Andreeff, Steven M. Kornblau, Charles Koller, Milosav Beran, Michael Keating, Mary Beth Rios, Jenny Shan, Debra Resta, Renaud Capdeville, Kimberly Hayes, Maher AlbitarEmil J. Freireich, Jorge E. Cortes

Research output: Contribution to journal › Article › peer-review

128 Scopus citations

Fingerprint

Dive into the research topics of 'Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-α: Follow-up results'. Together they form a unique fingerprint.

Medicine & Life Sciences